Li‐Yuan Bai

4.1k total citations
125 papers, 1.4k citations indexed

About

Li‐Yuan Bai is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Li‐Yuan Bai has authored 125 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Oncology, 31 papers in Molecular Biology and 27 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Li‐Yuan Bai's work include Pancreatic and Hepatic Oncology Research (20 papers), Gastric Cancer Management and Outcomes (15 papers) and Neuroendocrine Tumor Research Advances (12 papers). Li‐Yuan Bai is often cited by papers focused on Pancreatic and Hepatic Oncology Research (20 papers), Gastric Cancer Management and Outcomes (15 papers) and Neuroendocrine Tumor Research Advances (12 papers). Li‐Yuan Bai collaborates with scholars based in Taiwan, China and United States. Li‐Yuan Bai's co-authors include Chang‐Fang Chiu, Jing‐Ru Weng, Shenwei Wang, Kai Ou, Lixin Yi, Kexin Zhang, Jiankang Liu, Zifan Lu, Guodong Yang and Haiyan Fu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Li‐Yuan Bai

113 papers receiving 1.4k citations

Peers

Countries citing papers authored by Li‐Yuan Bai

Since Specialization

Citations

This map shows the geographic impact of Li‐Yuan Bai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li‐Yuan Bai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li‐Yuan Bai more than expected).

Fields of papers citing papers by Li‐Yuan Bai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li‐Yuan Bai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li‐Yuan Bai. The network helps show where Li‐Yuan Bai may publish in the future.

Co-authorship network of co-authors of Li‐Yuan Bai

This figure shows the co-authorship network connecting the top 25 collaborators of Li‐Yuan Bai. A scholar is included among the top collaborators of Li‐Yuan Bai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li‐Yuan Bai. Li‐Yuan Bai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Circulating miRNAs as potentially predictive biomarkers for chemoimmunotherapy in advanced biliary tract cancer: a post-hoc analysis of the phase II T1219 study 2025 ·npj Precision Oncology ·Nai‐Jung Chiang, (unknown), Li‐Yuan Bai, (unknown), Wei‐Ming Chen, (unknown), San‐Chi Chen, (unknown), Chia‐Hsun Hsieh	0
2	Dual amorphous coatings stabilize waste-derived Si@C@TiO2 anodes for high-stability lithium-ion batteries 2025 ·Journal of Electroanalytical Chemistry ·Li‐Yuan Bai, Chengdeng Wang, Zhi Wang, (unknown), (unknown), (unknown), (unknown), (unknown), Guoxiu Wang, Xiaoqin Yan	0
3	Coexistence of APC and KRAS Mutations in Familial Adenomatous Polyposis and Endometrial Cancer: A Mini‐Review With Case‐Based Perspective 2025 ·SHILAP Revista de lepidopterología ·Tao Yin, (unknown), Li‐Yuan Bai, (unknown), (unknown)	0
4	Venetoclax Plus Azacitidine as a Bridge Treatment to Allogeneic Stem Cell Transplantation in Unfit Patients with Acute Myeloid Leukemia 2024 ·Cancers ·(unknown), Ching‐Chan Lin, Wen-Jyi Lo, Ching-Yun Hsieh, (unknown), (unknown), Chen‐Yuan Lin, Li‐Yuan Bai, Chang‐Fang Chiu, Su‐Peng Yeh	2
5	Phase 1/2 study of NGM707, an ILT2/ILT4 dual antagonist antibody, in advanced solid tumors: Interim results from dose-escalation. 2024 ·Journal of Clinical Oncology ·Judy S. Wang, David Sommerhalder, Manish Sharma, William J. Edenfield, Kartik Sehgal, Do‐Youn Oh, Yixing Jiang, Joel Michalski, Jeeyun Lee, Hans J. Hammers, Li‐Yuan Bai, Chih‐Hung Hsu, (unknown), Kefei Zhou, Lisa K. Blum, (unknown), (unknown), Hsiao D. Lieu, Vladimir Hanes, Aung Naing	2
6	Phase I–II study of OBI-888, a humanized monoclonal IgG1 antibody against the tumor-associated carbohydrate antigen Globo H, in patients with advanced solid tumors 2024 ·Cancer Chemotherapy and Pharmacology ·Apostolia M. Tsimberidou, Axel Grothey, Darren Sigal, Heinz-Josef Lenz, Howard S. Höchster, Yee Chao, Li‐Yuan Bai, (unknown), (unknown), M. Wayne Saville	1
7	EZH2-mediated epigenetic silencing of tumor-suppressive let-7c/miR-99a cluster by hepatitis B virus X antigen enhances hepatocellular carcinoma progression and metastasis 2023 ·Cancer Cell International ·(unknown), (unknown), Chia‐Jui Yen, Jiayan Wu, Li‐Yuan Bai, Yung‐Luen Yu	9
8	Real-World Data Validation of NAPOLI-1 Nomogram for the Prediction of Overall Survival in Metastatic Pancreatic Cancer 2023 ·Cancers ·Yung‐Yeh Su, Nai‐Jung Chiang, Yi‐Hsin Yang, Chia‐Jui Yen, Li‐Yuan Bai, Chang‐Fang Chiu, Shih‐Chang Chuang, Shih‐Hung Yang, Wen‐Chi Chou, Jen‐Shi Chen, Tai‐Jan Chiu, Yen‐Yang Chen, De-Chuan Chan, Cheng‐Ming Peng, (unknown), Chung‐Pin Li, Yan‐Shen Shan, Li‐Tzong Chen	5
9	Systemic treatments in pancreatic cancer: Taiwan pancreas society recommendation 2023 ·Biomedical Journal ·Yung‐Yeh Su, Nai‐Jung Chiang, Tai‐Jan Chiu, (unknown), Shao‐Jung Hsu, (unknown), Shih‐Hung Yang, Youngsen Yang, Wen‐Chi Chou, Yen‐Yang Chen, Li‐Yuan Bai, Chung‐Pin Li, Jen‐Shi Chen	1
10	ILUSTRO: Phase II Multicohort Trial of Zolbetuximab in Patients with Advanced or Metastatic Claudin 18.2–Positive Gastric or Gastroesophageal Junction Adenocarcinoma 2023 ·Clinical Cancer Research ·Samuel J. Klempner, Keun‐Wook Lee, Kohei Shitara, Jean‐Philippe Metges, Sara Lonardi, David H. Ilson, Nicola Fazio, Tae‐Yong Kim, Li‐Yuan Bai, Diarmuid Moran, (unknown), Ahsan M. Arozullah, (unknown), Jeffrey J. Raizer, Yung‐Jue Bang, Manish A. Shah	44
11	The impact of preoperative waiting time in Stage II–III gastric or gastroesophageal junction cancer: A population‐based cohort study 2023 ·Cancer Medicine ·(unknown), Yi‐Hsin Yang, Hsiu‐Ying Ku, Huang‐Ming Hu, Su‐Shun Lo, Hung‐Chi Chang, Yee Chao, Jen‐Shi Chen, Hsiu‐Po Wang, (unknown), Li‐Yuan Bai, Ming‐Shiang Wu, Chia‐Jui Yen, Li‐Tzong Chen, Yan‐Shen Shan	3
12	Impaired Chromatin Remodeling Predicts Better Survival to Modified Gemcitabine and S-1 plus Nivolumab in Advanced Biliary Tract Cancer: A Phase II T1219 Study 2022 ·Clinical Cancer Research ·(unknown), Kien Thiam Tan, Li‐Yuan Bai, Chin‐Fu Hsiao, Chung‐Yu Huang, Yi‐Ping Hung, (unknown), San‐Chi Chen, Yan‐Shen Shan, Yee Chao, Yi‐Hsiang Huang, I‐Cheng Lee, Pei‐Chang Lee, Yung‐Yeh Su, Shu‐Jen Chen, Chun‐Nan Yeh, Li‐Tzong Chen, Ming‐Huang Chen	13
13	Antithymocyte globulin plus post-transplant cyclophosphamide combination as graft-versus-host disease prophylaxis in haploidentical peripheral blood stem cell transplantation for hematological malignancies 2022 ·International Journal of Hematology ·Tzu‐Ting Chen, Ching‐Chan Lin, Wen-Jyi Lo, Ching-Yun Hsieh, (unknown), (unknown), (unknown), Li‐Yuan Bai, Chang‐Fang Chiu, Su‐Peng Yeh	8
14	High rate of invasive fungal infections during early cycles of azacitidine for patients with acute myeloid leukemia 2022 ·Frontiers in Cellular and Infection Microbiology ·(unknown), (unknown), Tzu‐Ting Chen, Ching‐Chan Lin, Li‐Yuan Bai, (unknown), Mao‐Wang Ho, (unknown)	9
15	Vacuum Evaporation of High-Quality CsPbBr3 Thin Films for Efficient Light-Emitting Diodes 2022 ·Nanoscale Research Letters ·(unknown), Shenwei Wang, Li‐Yuan Bai, Kexin Zhang, (unknown), Lixin Yi	13
16	Negative prognostic implications of splenomegaly in nivolumab-treated advanced or recurrent pancreatic adenocarcinoma 2021 ·OncoImmunology ·Shih‐Hung Yang, Li‐Chun Lu, Hsiang‐Fong Kao, Bang‐Bin Chen, Ting‐Chun Kuo, Sung‐Hsin Kuo, Yu‐Wen Tien, Li‐Yuan Bai, Ann‐Lii Cheng, Kun‐Huei Yeh	6
17	Influence of annealing temperature on photoluminescence of CePO4 thin films on silicon substrates prepared by electron beam evaporation 2018 ·Optik ·Yu Wang, Shenwei Wang, Kai Ou, Yanwei Zhang, Li‐Yuan Bai, Lixin Yi	3
18	Editor’s Highlight: Effects of Intraperitoneal Injection of SnS2 Flowers on Mouse Testicle 2017 ·Toxicological Sciences ·(unknown), Qingzhao Li, (unknown), Junjian Zhao, Li‐Yuan Bai, (unknown), Yuan Lu, Ping Wu	10
19	Helicobacter pylori infection and lung cancer: a review of an emerging hypothesis 2013 ·Carcinogenesis ·Bo Deng, Yafei Li, Ying Zhang, Li‐Yuan Bai, Ping Yang	41
20	Non‐Hodgkin lymphoma in elderly patients 2003 ·Cancer ·Li‐Yuan Bai, Muh‐Hwa Yang, Tzeon‐Jye Chiou, Liu H, Chueh‐Chuan Yen, Wei‐Shu Wang, Liang‐Tsai Hsiao, Ta‐Chung Chao, Po‐Min Chen	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact